TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biogen Norway AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
168,361
|
200,902
|
287,378 |
Financial expenses |
10
|
164
|
291 |
Earnings before taxes |
8,084
|
6,756
|
13,110 |
Total assets |
139,733
|
140,160
|
161,468 |
Current assets |
139,613
|
139,976
|
161,215 |
Current liabilities |
24,925
|
24,542
|
44,996 |
Equity capital |
114,808
|
115,618
|
116,473 |
- share capital |
66
|
71
|
75 |
Employees (average) |
26
|
19 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
82.2%
|
82.5%
|
72.1% |
Turnover per employee |
7,727
|
15,125 | |
Profit as a percentage of turnover |
4.8%
|
3.4%
|
4.6% |
Return on assets (ROA) |
5.8%
|
4.9%
|
8.3% |
Current ratio |
560.1%
|
570.4%
|
358.3% |
Return on equity (ROE) |
7.0%
|
5.8%
|
11.3% |
Change turnover |
-20,196
|
-71,382
|
-65,622 |
Change turnover % |
-11%
|
-26%
|
-19% |
Chg. No. of employees |
7
|
2 | |
Chg. No. of employees % |
37%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.